<html><head><meta http-equiv="content-type" content="text/html; charset=utf-8"></head><body dir="auto"><div><span></span></div><div><meta http-equiv="content-type" content="text/html; charset=utf-8"><div>Dear Dr Modabber</div><div>I am sending Prof. Mayrink's email address.</div><div>Best wishes</div><div>George L L Machado-Coelho<br><br>Sent from my iPhone</div><div><br>On 2 Dec 2013, at 11:29, Farrokh Modabber <<a href="mailto:fmodabber@dndi.org">fmodabber@dndi.org</a>> wrote:<br><br></div><blockquote type="cite"><div>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Calibri","sans-serif";
        color:windowtext;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri","sans-serif";}
@page WordSection1
        {size:8.5in 11.0in;
        margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
<div class="WordSection1">
<p class="MsoNormal">Dear Colleagues,<o:p></o:p></p>
<p class="MsoNormal">I recall from Prof. Mayrinks studies, that BCG vaccination may convert leishmanin skin test in some volunteers who are LST-negative (MST-negative). The reactivity would gradually diminish after a few months. Would appreciate any information
on that and on Prof. Mayrink’s current email address.<o:p></o:p></p>
<p class="MsoNormal">Many thanks,<o:p></o:p></p>
<p class="MsoNormal">Farrokh Modabber<o:p></o:p></p>
</div>
<br><br>--<br>
<i> This email was sent by <a href="http://icb.usp.br">icb.usp.br</a> </i>
</div></blockquote><blockquote type="cite"><div><span>_______________________________________________</span><br><span>Leish-l mailing list</span><br><span><a href="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a></span><br><span><a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a></span><br><span></span><br><span>--</span><br><span>This email was sent by <a href="http://icb.usp.br">icb.usp.br</a></span><br></div></blockquote></div></body></html>